Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03924765 · ClinicalTrials.gov registry record · NA

Assistive Hip Exoskeleton Study for Stroke

A NA study of Stroke and Lower Limb Injury, sponsored by Georgia Institute of Technology.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT03924765: Completed NA study of Stroke and Lower Limb Injury, sponsored by Georgia Institute of Technology.

NCT03924765 is a NA study of Stroke and Lower Limb Injury that has completed, run by Georgia Institute of Technology. The registered enrollment target is 10 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03924765, a NA study of Stroke and Lower Limb Injury, has completed, sponsored by Georgia Institute of Technology.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The increased metabolic and biomechanical demands of ambulation limit community mobility in persons with lower limb disability due to neurological damage. There is a critical need for improving the locomotion capabilities of individuals with stroke to increase their community mobility, independence, and health. Robotic exoskeletons have the potential to assist these individuals by increasing community mobility to improve quality of life. While these devices have incredible potential, current technology does not support dynamic movements common with locomotion such as transitioning between different gaits and supporting a wide variety of walking speeds. One significant challenge in achieving community ambulation with exoskeletons is providing an adaptive control system to accomplish a wide variety of locomotor tasks. Many exoskeletons today are developed without a detailed understanding of the effect of the device on the human musculoskeletal system. This research is interested in studying the question of how the control system affects stroke biomechanics including kinematic, kinetics and muscle activation patterns. By optimizing exoskeleton controllers based on human biomechanics and adapting control based on task, the biggest benefit to patient populations will be achieved to help advance the state-of-the-art with assistive hip exoskeletons.

Primary Outcome

Using five different hip exoskeleton assistance strategies, the participant's overground self-selected walking speed was recorded. Assistance types are 1) Unilateral Paretic Assistance, 2) Unilateral Non-Paretic Assistance, 3) Bilateral Equal Assistance, 4) Bilateral Additional Paretic Assistance, and 5) Bilateral Additional Non-Paretic Assistance. The first information (unilateral or bilateral) refers to the leg(s) that the exoskeleton is providing assistance with. For example, unilateral assis

Conditions Studied

Interventions

  • DEVICE Powered hip exoskeleton

Study Locations (1)

Georgia

  • Exoskeleton and Prosthetic Intelligent Controls Lab - Atlanta

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-07-24
Est. Completion 2020-11-19
Phase NA
Georgia Institute of Technology

24 total trials

What the finished NCT03924765 record still lists

NCT03924765 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Powered hip exoskeleton is the first listed.

NCT03924765 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT03924765 about?

NCT03924765 is a clinical study titled "Assistive Hip Exoskeleton Study for Stroke". The increased metabolic and biomechanical demands of ambulation limit community mobility in persons with lower limb disability due to neurological damage. There is a critical need for improving the locomotion capabilities of individuals with stroke to increase their community mobility, independence,...

What is the current status of trial NCT03924765?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-07-24. Estimated completion is 2020-11-19.

What conditions does trial NCT03924765 study?

This clinical trial studies the following conditions: Stroke, Lower Limb Injury.

What interventions are being tested in trial NCT03924765?

The interventions under investigation include: Powered hip exoskeleton (DEVICE).

Who is sponsoring clinical trial NCT03924765?

This trial is sponsored by Georgia Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03924765 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03924765's enrollment target sits among peer trials

10 415th of 454 higher than 30 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

  • NCT01870752 · 10 participants · NA

    Ovarian Tissue Transplantation

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03924765, the US trial registry maintained by the National Library of Medicine. NCT03924765 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.